Cargando…
Antiviral Potential of Small Molecules Cordycepin, Thymoquinone, and N6, N6-Dimethyladenosine Targeting SARS-CoV-2 Entry Protein ADAM17
COVID-19 is an acute respiratory disease caused by SARS-CoV-2 that has spawned a worldwide pandemic. ADAM17 is a sheddase associated with the modulation of the receptor ACE2 of SARS-CoV-2. Studies have revealed that malignant phenotypes of several cancer types are closely relevant to highly expresse...
Autores principales: | He, Jiayue, Liu, Shuguang, Tan, Qi, Liu, Zhiying, Fu, Jiewen, Li, Ting, Wei, Chunli, Liu, Xiaoyan, Mei, Zhiqiang, Cheng, Jingliang, Wang, Kai, Fu, Junjiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9781528/ https://www.ncbi.nlm.nih.gov/pubmed/36558177 http://dx.doi.org/10.3390/molecules27249044 |
Ejemplares similares
-
The Correlation Between Immune Invasion and SARS-COV-2 Entry Protein ADAM17 in Cancer Patients by Bioinformatic Analysis
por: Wang, Kai, et al.
Publicado: (2022) -
PCIF1, the only methyltransferase of N6,2-O-dimethyladenosine
por: Wu, Yuting, et al.
Publicado: (2023) -
Comprehensive analysis, immune, and cordycepin regulation for SOX9 expression in pan-cancers and the matched healthy tissues
por: Liu, Shuguang, et al.
Publicado: (2023) -
Formation and removal of 1,N(6)-dimethyladenosine in mammalian transfer RNA
por: You, Xue-Jiao, et al.
Publicado: (2022) -
Dynamic regulation of N(6),2′-O-dimethyladenosine (m(6)Am) in obesity
por: Ben-Haim, Moshe Shay, et al.
Publicado: (2021)